Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Capital Employed (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Return on Capital Employed for 15 consecutive years, with 0.4% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 11.0% year-over-year to 0.4%, compared with a TTM value of 0.4% through Sep 2025, down 11.0%, and an annual FY2024 reading of 0.43%, down 36.0% over the prior year.
  • Return on Capital Employed was 0.4% for Q3 2025 at China Pharma Holdings, up from 0.42% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.02% in Q3 2023 and bottomed at 0.5% in Q4 2024.
  • Average Return on Capital Employed over 5 years is 0.24%, with a median of 0.23% recorded in 2022.
  • The sharpest move saw Return on Capital Employed surged 36bps in 2022, then tumbled -42bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.09% in 2021, then plummeted by -167bps to 0.23% in 2022, then soared by 63bps to 0.08% in 2023, then plummeted by -492bps to 0.5% in 2024, then increased by 21bps to 0.4% in 2025.
  • Business Quant data shows Return on Capital Employed for CPHI at 0.4% in Q3 2025, 0.42% in Q2 2025, and 0.47% in Q1 2025.